A nonprofit recently reported that, since 2009, the National Institutes of Health and many of its scientists received an estimated $350 million in royalties for developing experimental treatments.
I have discussed Fossil Group (FOSL) previously, so investors should view this as an update to my earlier coverage of the company. It's been a wild ride for shareholders of lifestyle accessories giant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results